Novel mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy
Methods for treating neuroblastoma in a subject are provided. The methods include administering to the subject nucleic acid that is capable of causing a significant reduction of the amount of doublecortin like protein (DCL) in the subject. The nucleic acids include antisense oligonucleotides and small interfering RNA.
VREUGDENHIL ERNO [NL]; VAN KUIK-ROMEIJN PETRA [NL]
Type of Offer:
« More Biotech Patents« More Genetics Patents